Heptaminol hydrochloride

CAS No. 543-15-7

Heptaminol hydrochloride( Arcor tropfen, Cardiosintol, Corasor, Delmiton, EA-85, Heptaminol HCl, Heptaminol hydrochloride, Respirin )

Catalog No. M14947 CAS No. 543-15-7

Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 88 In Stock
500MG 138 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Heptaminol hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.
  • Description
    Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Arcor tropfen, Cardiosintol, Corasor, Delmiton, EA-85, Heptaminol HCl, Heptaminol hydrochloride, Respirin
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    543-15-7
  • Formula Weight
    181.71
  • Molecular Formula
    C8H20ClNO
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    Cl.CC(N)CCCC(C)(C)O
  • Chemical Name
    2-Heptanol, 6-amino-2-methyl-, hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.GARRETT J. Arch Int Pharmacodyn Ther. 1954 Nov 1;100(1):17-34.
molnova catalog
related products
  • Enoximone

    Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.

  • LJI308

    LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.

  • Tovinontrine

    Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment.